Clinical Trials Logo

Phobia, Social clinical trials

View clinical trials related to Phobia, Social.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06370559 Completed - Anxiety Disorders Clinical Trials

Relationship Between Repetitive Negative Thinking and CBT Outcomes

Start date: January 1, 2022
Phase:
Study type: Observational

The goal of this observational study is to learn about the role of repetitive negative thinking (measured by the RTQ) in adult populations from an anxiety disorders and trauma clinic. The main questions it aims to answer are: - Whether the repetitive negative thinking can be used to predict i. initial symptom severity, and ii. therapy outcome (measured by change in scores on disorder specific measures). - Whether change in RTQ mediates change in outcome Participants are sent weekly questionnaires that measure their progress. Within these questionnaires are the RTQ and other disorder-specific measures that we will be analysing. Researchers may also compare clients with different disorders to see the accuracy the RTQ can predict treatment outcomes for each disorder.

NCT ID: NCT06037668 Completed - Clinical trials for Social Anxiety Disorder (SAD)

A Randomized, Controlled Study of Two At-Home Self-Guided Virtual Reality Interventions for Adults With Social Anxiety Disorder.

BVR-100-102
Start date: September 8, 2023
Phase: N/A
Study type: Interventional

This study is to compare two Virtual Reality (VR)-based interventions, BVR-100 and BES-100, for the treatment of Social Anxiety Disorder (SAD).

NCT ID: NCT05987969 Completed - Clinical trials for Social Anxiety Disorder

Efficacy and Safety of the Alena App as a Treatment for Social Anxiety Disorder

Start date: March 20, 2023
Phase: N/A
Study type: Interventional

The present study is a randomised controlled trial that seeks to investigate the efficacy and safety of the Alena app as a treatment for social anxiety disorder.

NCT ID: NCT05913557 Completed - Clinical trials for Obsessive-Compulsive Disorder

Radical Openness for Adolescents Pilot

ROA
Start date: August 11, 2020
Phase: Early Phase 1
Study type: Interventional

Heightened performance monitoring and overcontrol (HPM/OC) is characterized by inflexibility, a need for control, perfectionism, anxious apprehension and high error monitoring. HPM/OC is a cross-diagnostic (transdiagnostic) characteristic occurring across multiple forms of psychiatric illness that emerge in adolescence, including anorexia nervosa (AN), obsessive compulsive disorder (OCD) and social anxiety disorder. This study characterizes behavioral and neural HPM/OC in healthy adolescents and adolescents with disorders characterized by HPM/OC, including AN and related eating disorders and anxiety, depressive and obsessive compulsive disorders. We then examine feasibility of a novel treatment for HPM/OC in adolescents, examining recruitment feasibility, exploration of the mechanism of HPM/OC and examining whether treatment is able to target neural and behavioral HPM/OC.

NCT ID: NCT05858294 Completed - Clinical trials for Social Anxiety Disorder

The Safety, Acceptability and Efficacy of Alena

Start date: October 31, 2022
Phase: N/A
Study type: Interventional

The present study is a randomised controlled trial that seeks to investigate the safety, acceptability and efficacy and safety of the Alena CBT programme as a treatment for social anxiety disorder.

NCT ID: NCT05612425 Completed - Eating Disorders Clinical Trials

Text Message Safety Behavior Fading for Appearance Concerns

Start date: January 12, 2024
Phase: N/A
Study type: Interventional

The current study aims to explore the efficacy of a text message based safety behavior fadinig intervention compared to an unhealthy behavior fading intervention for appearance concerns.

NCT ID: NCT05576259 Completed - Social Anxiety Clinical Trials

oVRcome - Self Guided Virtual Reality for Social Anxiety Disorder

Start date: October 8, 2022
Phase: N/A
Study type: Interventional

Social anxiety is characterised by excessive fear of being negatively judged, embarrassed or humiliated during social interactions and is common with a lifetime prevalence of 12.1%. Cognitive behavioural therapy is the first line of treatment, but people may not seek treatment due to a number of factors including the discomfort experienced in seeking help, inconvenience, and the experience of psychotherapy itself. With Virtual Reality (VR), users can have increased control in how gradually they expose themselves to social situations. In studies of VR in people with specific phobias, 76% of people prefer VR exposure to in vivo exposure. There is emerging evidence for the use of VR in social phobia. oVRcome, is a self-help VRET for social anxiety symptoms and specific phobias, that is delivered through a smartphone application (app) in combination with a low cost headset that holds the smartphone and uses 360º video. This study will evaluate the effectiveness of the oVRcome social anxiety program for social anxiety symptoms. We hypothesize that oVRcome will reduce social anxiety symptom severity over a 6-week treatment period compared to waiting-list control

NCT ID: NCT05284435 Completed - Clinical trials for Autism Spectrum Disorder

Internet-Based, Parent-Led Cognitive-Behavioral Therapy for Anxiety in Youth With ASD

Start date: March 28, 2022
Phase: N/A
Study type: Interventional

This study compares the effectiveness of two levels of therapist support for an internet-based, parent-led cognitive behavioral therapy for youth with anxiety and ASD.

NCT ID: NCT05261659 Completed - Sleep Clinical Trials

Targeted Memory Reactivation During REM Sleep in Patients With Social Anxiety Disorder

Start date: February 18, 2020
Phase: N/A
Study type: Interventional

With this study, the investigators aim to use sleep and dreaming in order to enhance exposure therapy for social anxiety disorder (SAD), by pairing the positive feedback phase of exposure (public talk) to an auditory stimulus during wake (associated sound) and subsequently applying this stimulus during sleep (targeted memory reactivation, TMR). Exposure therapy sessions will take place in a virtual reality (VR) environment, while physiological measures during the preparation phase of public talk such as heart rate variability (HRV), skin conductance response (SCR) and subjective level of anxiety (SUDS) will be used in order to assess treatment efficiency across the sessions. Patients with SAD according to DSM-5 criteria will be included. The main hypothesis of this study is that participants who are presented with the associated sound during sleep (TMR group) will have reduced intensity of social anxiety compared to participants with no such association (control group), after both a full night's sleep with auditory stimulation during REM sleep in the laboratory, and after 1 week of stimulation during REM sleep at home. In addition, it is expected that fear-related dreams may correlate with anxiety levels during wakefulness after 1 week of stimulation at home.

NCT ID: NCT05240794 Completed - Clinical trials for Social Anxiety Disorder

Effects of Therapeutic Mobile Game on Anxiety

Start date: June 15, 2022
Phase: N/A
Study type: Interventional

Participants with Social Anxiety Disorder (SAD) will use a digital therapeutic for 30 days, and will complete assessments measuring a broad range of anxiety and mood-related symptoms, with a focus on SAD symptoms, and metrics of functional impairment during this time. After the treatment period, participants will be followed at 6 month and 12 month after the completion of the study.